+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID06288152

Study of Sodium Thiosulfate Added to Kidney Preservation Solution for Improving Outcomes in Deceased Donor Kidney Transplantation

Led by Alp Sener · Updated on 2026-04-13

120

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

End-stage renal disease ESRD is a serious condition requiring dialysis or kidney transplantation. Due to the shortage of living donors, kidneys from deceased donors, including neurologically deceased donors NDD and donation after cardiac death donors DCD, are increasingly used. However, these kidneys face higher risks of injury and delayed function due to lack of blood supply and cold preservation effects. Researchers are studying the addition of sodium thiosulfate STS, a hydrogen sulfide donor, to kidney preservation solutions to improve kidney viability and transplant outcomes.

CONDITIONS

Brief Title

Evaluation of Thiosulfate Enhanced Organ Preservation Solution in Kidney Transplantation

Research Team

C

Cadence Baker

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here